Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 26, 2015 - Issue 3
Submit an article Journal homepage
300
Views
3
CrossRef citations to date
0
Altmetric
Original Article

A randomised, controlled trial of a 4% cutaneous emulsion of sodium cromoglicate in treatment of atopic dermatitis in children

John Berth-JonesDermatology Department, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK,
,
Ian PollockPaediatric Department, Chase Farm Hospital, The Ridgeway, Enfield, Middlesex, UK,
,
Ross M. R. HearnDermatology Department, Ninewells Hospital, Dundee, Tayside, Scotland,
,
Sue Lewis-JonesDermatology Department, Ninewells Hospital, Dundee, Tayside, Scotland,
,
Mark GoodfieldDermatology Department, The Leeds Teaching Hospital NHS Trust, Leeds, West Yorkshire, UK,
,
Christopher E. M. GriffithsDermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK,
,
Ram GulatiDermatology Department, Royal Hospital for Sick Children, Yorkhill, Glasgow, Scotland,
,
Pamela McHenryDermatology Department, Royal Hospital for Sick Children, Yorkhill, Glasgow, Scotland,
,
Anthony AbdullahThe Birmingham Skin Centre, City Hospital, Birmingham, UK,
,
Jennifer OttDermatology Department, St. Luke’s Hospital, Bradford, West Yorkshire, UK,
,
Andrew WrightDermatology Department, St. Luke’s Hospital, Bradford, West Yorkshire, UK,
,
Benjamin WalkerDermatology Department, Harrogate and District Foundation Trust, Harrogate, UK,
,
Michael T. StevensEmStat Ltd., Leicester, UK, and
&
Alan M. EdwardsThe David Hide Asthma and Allergy Research Centre, St. Mary’s Hospital, Newport, Isle of Wight, UKCorrespondence[email protected]
 show all
Pages 291-296 | Received 06 May 2014, Accepted 15 Jul 2014, Published online: 07 Aug 2014

References

  • Yang Y, Lu JY-L, Wu X, et al. G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium. Pharmacology. 2010;86:1–5
  • Edwards AM, Stevens MT, Church MK. The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial. BMC Res Notes. 2011;4:47
  • Vieira Dos SR, Magerl M, Martus P, et al. Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus. Br J Dermatol. 2010;162:674–6
  • Haider SA. Treatment of atopic eczema in children. A clinical trial of 10% SCG ointment. Br Med J. 1977;1:1570–2
  • Thirumoothy T, Greaves MW. Disodium cromoglycate ointment in atopic eczema. Br Med J. 1978;2:500–1
  • Croner S, Fagerlund L, Kjellman NI, et al. Sodium cromoglycate ointment in atopic eczema during childhood. Opuscula Medica. 1981;26:49–50
  • Zachariae H, Thestrup-Pedersen K, Thulin H, et al. Experimental treatment in atopic dermatitis: immunological background and preliminary results. Acta Dermatovener (Stockholm) Suppl. 1980;92:121–7
  • Kjellman NI, Gustafsson IM. Topical sodium cromoglycate in atopic dermatitis. A disappointing but informative trial. Allergy. 1986;41:423–8
  • Pike MG, Atherton DJ. Failure of a new topical sodium cromoglycate formulation to improve atopic dermatitis [letter]. Eur J Pediatr. 1988;148:170–2
  • Ariyanayagam M, Barlow TJ, Graham P, et al. Topical sodium cromoglycate in the management of atopic eczema – a controlled trial. Br J Dermatol. 1985;112:343–8
  • Kimata H, Igarashi M. Topical cromolyn (disodium cromoglycate) solution in the treatment of young children with atopic dermatitis. Clin Exp Allergy. 1990;20:281–3
  • Kimata H, Hiratsuka S. Effect of topical cromoglycate solution on atopic dermatitis: combined treatment of sodium cromoglycate solution with the oral anti-allergic medication, oxatomide. Eur J Pediatr. 1994;153:66–71
  • Hiratsuka S, Yoshida A, Ishioka C, Kimata H. Enhancement of in vitro spontaneous IgE production by topical steroids in patients with atopic dermatitis. J Allergy Clin Immunol. 1996;98:107–13
  • Stainer R, Matthews S, Arshad SH, et al. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm), in atopic dermatitis in children aged 2–12 years: a double-blind, randomized, placebo-controlled trial. Br J Dermatol. 2005;152:334–41
  • Submitted for publication EudraCT No:2004-003901-25
  • Williams HC, Burney PGJ, Pembroke AC, Hay RH. The UK working party’s diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol. 1994;131:406–17
  • Staider JF, Taieb A. European Task Force on Atopic Dermatitis: severity scoring of atopic dermatitis: the SCORAD Index. Dermatology. 1993;186:23–31
  • Schmitt J, Langna S, Deckert S, et al. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol. 2013;132:1337–47
  • Berth-Jones J. Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol. 1996;135 Suppl 48:25–30
  • Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132:942–9
  • Lewis-Jones MS, Finlay AY, Dykes PJ. The Infants’ Dermatitis Quality of Life Index. Br J Dermatol. 2001;144:104–10
  • Breuer K, Werfel T, Kapp A. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Am J Clin Dermatol. 2005;6:65–77
  • Fleischer AB, Abramovits W, Breneman D, Jaracz E. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis. J Dermatol Treatment. 2007;18:151–7, doi:10.1080/09546630701287332
  • Beiber TI, Vick K, Folster-Holst R, et al. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy. 2007;62:184–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.